Genezen: Funding, Investors & Team (Sep 2026)
Genezen, founded in 2014 in Indianapolis, is dedicated to meeting the needs of the global gene and cell therapy manufacturing market. They aim to provide viral vector production services that are accessible to both emerging companies and established industry leaders. The company offers services in early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing. Genezen leverages its extensive industry knowledge and expertise gained from collaborating with top institutions in the country. To find out more information or inquire about the services available at Genezen's new cGMP facility, please visit their website: www.genezen.com.
Genezen has raised $18.5M across 1 funding round on record, the most recent an undisclosed round of $18.5M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genezen Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Genezen Funding Rounds
Genezen Founders and Leadership Team
No contact details are on record for this team yet.
Genezen Funding Compared to Other Biotechnology Startups
Genezen's latest round of $18.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genezen in Biotechnology and Indianapolis
Companies Similar to Genezen
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Genezen Funding FAQs
What does Genezen do?
Genezen, founded in 2014 in Indianapolis, is dedicated to meeting the needs of the global gene and cell therapy manufacturing market. They aim to provide viral vector production services that are accessible to both emerging companies and established industry leaders. The company offers services in early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing. Genezen leverages its extensive industry knowledge and expertise gained from collaborating with top institutions in the country. To find out more information or inquire about the services available at Genezen's new cGMP facility, please visit their website: www.genezen.com.
How much funding has Genezen raised?
Genezen has raised $18.5M across 1 round on record. The most recent is an undisclosed round of $18.5M announced in Nov 2023.
When did Genezen last raise funding?
Genezen's most recent funding round on record is an undisclosed round of $18.5M, announced in Nov 2023.
Who founded Genezen?
FundedIQ lists Bill Vincent (Founder) at Genezen.
Where is Genezen headquartered?
Genezen is based in Indianapolis, Indiana, United States.
How many employees does Genezen have?
Genezen is in the 51-100 employee band.
How does Genezen's funding compare to other Biotechnology startups?
Genezen's latest round of $18.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Genezen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genezen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.